 Red cell antibodies solid organ transplants RBC antibodies organs recipient RBCs well-established immunohematologic complication solid organ transplantation ABO-unmatched organs frequency severity graft antibodies hemolysis size lymphoid content organ kidney heart-lung transplants cases frequency hemolysis cyclosporine-treated kidney transplant recipients O-to-A liver transplant recipients group AB liver transplant recipients kidney transplant recipients azathioprine low-dose postoperative graft irradiation Available data distinguish cyclosporine-treated recipients ABO-unmatched kidneys livers total graft antibody conclusive effect date age race gender donor recipient cadaver versus kidney donors patients secretor status cases living-donor kidney grafts donor patient mother wife recipient RBC pregnancy ABO antibodies IgG days transplantation last month immediate-spin crossmatching DATs compatibility testing ABO-unmatched transplants Changes immunosuppressive regimen change cyclosporine therapy duration antibodies patients transfusions self-limited process cases hemolysis-induced acute renal failure death complications hemolysis RBC plasma exchange fulminant cases RBCs donor blood type antibody workers transfusion prophylaxis time surgery liver transplants plasma large amount group RBCs problematic several centers ABO-unmatched liver transplants equivalent overall graft survivals Pittsburgh adult patients hemolysis early graft survival cases IgG Rh antibodies kidney grafts recipient RBCs weeks cyclosporine-treated transplant months operation mild hemolysis case primary immune response unsensitized donor ABSTRACT TRUNCATED AT WORDS